Pharmafile Logo

Lucid Group Elevates its Editorial Centre of Excellence – COMET

- PMLiVE

Lucid Group has been busy expanding and operationalising its editorial team – COMET (Centre Of Medical EdiTing) – to ensure its successful integration into Lucid Group. This has been achieved through the establishment of COMET Ambassadors, who are leading pilot projects and advocating best working practices. Not only has Lucid Group bolstered the number of editors who make up COMET but the team is also specifically trained in medical editing and is now formally accredited by CIEP (Chartered Institute of Editing and Proofreading).

COMET is headed up by Liz Jennings, Associate Editorial Director, who enthuses, “We’re thrilled that Lucid Group sees the value in sponsoring individual membership of CIEP for COMET team members. This allows our editors to gain merits across a core-training copyediting and proofreading programme, both with CIEP and with our own programme, to ensure our ‘right first time’ ethos produces high-quality work and consistent standards for our clients.”

This accreditation complements the qualified status of Lucid Group’s medical writers, adding gravitas to its editing centre of excellence with this trailblazing initiative for its in-house medical editors.
Lucid Group’s human-centric and pioneering spirit has always been at the core of its culture, and the way it has evolved. COMET is testament to this, developing and nurturing talent to facilitate an industry-leading experience for both employees and clients.

If you’re interested in being part of something magical, please get in touch.
Contact Dan Newbury, Talent Acquisition Manager
Email: daniel@lucid-group.co.uk
Tel: 07584 575260

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

A summer meeting full of magical moments

In their day-to-day, everybody at Lucid Group strives to develop outstanding medical education programmes to improve patient outcomes. Over the summer, however, they like to take some time to turn...

Sir Henry presents Queen’s Award for Enterprise to Lucid Group

On 13 July, Lord Lieutenant Sir Henry presented Lucid Group with the Queen’s Award for Enterprise in International Trade. This award recognises UK-based businesses that have achieved outstanding growth overseas...

Lucid Group’s winning formula is recognised at Communiqué 2017

Lucid Group’s commitment to improving patient outcomes across the globe was recognised at the 2017 Communiqué Awards in London last night. The agency won the awards for Excellence in Communications...

Lucid Partners grows its medical writing team

The past year has been the most successful for Lucid Group yet. They have celebrated their 10th year of business, launched their new Strategic Consultancy, won a Queen’s Award for...

Using insights to effect behaviour change

The days when medical communication simply aimed to raise awareness of clinical challenges are well and truly over. In recent years, we have seen a clear shift towards changing physicians’...

All five of Lucid’s entries reach the shortlist for Communiqué 2017

Lucid Group is thrilled to learn that all its entries for the 2017 Communiqué Awards have been shortlisted as finalists! The categories include: Communications Consultancy of the Year Lucid Group   Excellence in Communications via...

Your career starts here

When working in medical communications, one of the most common questions we get asked is “What is it that you actually do?” Many students and graduates are unaware of medical...

Are you suffering from templatitis?

At times, it feels like procedures are designed to frustrate, and templates often hinder rather than help. Especially in strategic planning, where a certain degree of creativity and innovation is...

It’s time to shine for Lucid’s rare disease team

No team members were getting their hands dirty today! Instead, they were treated to car valets and manicures as a thank you for all their hard work delivering a number...

Focus on Rare Diseases

As pharma becomes more focused on rare disease therapies, Lucid Group recognises that medical education agencies need to respond.